Study to assess the efficacy of ginsana in improving half-time hemoglobin re-oxygenation in healthy, recreational sportspeople and to assess the safety of the product

Inclusion Criteria:

• Male and female volunteers between 18 and 40 years old
• Females must test negative for pregnancy
• Recreational athletes according to the american college of sports medicine (ACSM) definition
• Familiar with the cycle ergometer exercise methodology
• Written inform consent according to good clinical practice (GCP) and local regulations

Exclusion Criteria:

• Pre-treatment (less than 2 weeks prior to inclusion in this trial) and/or concomitant treatment with any drug that any drug that could have influence the trail methodology
• Alcohol and drug abuse (as defined in Diagnostic and Statistic Manual IV( DSM-IV)) per subject verbal report
• Smokers
• Known hypertension
• Known hypercholesterolemia (moderate/severe)
• Female volunteers taking oral or injectable contraceptives
• Female volunteers of child bearing potential not using adequate means of birth control, other than contraceptive pills [intrauterine devices (IUDs)]
• Pregnancy and/or lactation
• Liver and/or renal disease and/or vascular disease
• Relevant allergy or known hypersensitivity to the investigational drug or its excipients
• Participation in another clinical trial within the last 4 weeks and concurrent participation in another clinical trial